‘Pulsed’ immunosuppressive therapy in the treatment of immunologically induced corneal and scleral disease
- 1 July 1987
- journal article
- research article
- Published by Springer Nature in Eye
- Vol. 1 (4) , 487-495
- https://doi.org/10.1038/eye.1987.73
Abstract
‘Pulsed’ immunosuppressive therapy, using methylprednisolone with or without cyclophosphamide, has effectively controlled severe destructive corneal and scleral disease that had been unresponsive to oral steroids. Thirty-seven patients have been treated in this manner and the results, complications and possible mechanism of action are discussed.Keywords
This publication has 48 references indexed in Scilit:
- Intravenous Pulse Methylprednisolone Therapy of Acute Primary Crescenteric Rapidly Progressive GlomerulonephritisScandinavian Journal of Rheumatology, 1984
- PREDNISOLONE PULSES IN COLLAGEN DISEASE: GRAMMES OR MILLIGRAMMES?The Lancet, 1983
- Pulse methylprednisolone therapy in diffuse proliferative lupus nephritisThe Journal of Pediatrics, 1982
- Methylprednisolone pulse therapy in the treatment of polyarteritis nodosaPublished by Oxford University Press (OUP) ,1977
- Cyclophosphamide therapy and interstitial pulmonary fibrosisCancer, 1976
- Corticosteroids inhibit prostaglandin production by rheumatoid synoviaNature, 1975
- CYCLOPHOSPHAMIDE THERAPY AND STERILITYThe Lancet, 1972
- Inhibition of lymphocyte recirculation by stress and corticotropinCellular Immunology, 1972
- ACUTE HEMOLYTIC ANEMIA ASSOCIATED WITH ADMINISTRATION OF ALKYLATING AGENTSThe Lancet Healthy Longevity, 1967
- Chromosome polyploidization in human leukocyte cultures treated with streptonigrin and cyclophosphamideCancer, 1967